Literature DB >> 15899791

DNA ligase III as a candidate component of backup pathways of nonhomologous end joining.

Huichen Wang1, Bustanur Rosidi, Ronel Perrault, Minli Wang, Lihua Zhang, Frank Windhofer, George Iliakis.   

Abstract

Biochemical and genetic studies support the view that the majority of DNA double-strand breaks induced in the genome of higher eukaryotes by ionizing radiation are removed by two pathways of nonhomologous end joining (NHEJ) termed D-NHEJ and B-NHEJ. Whereas D-NHEJ depends on the activities of the DNA-dependent protein kinase and DNA ligase IV/XRCC4, components of B-NHEJ have not been identified. Using extract fractionation, we show that the majority of DNA end joining activity in extracts of HeLa cells derives from DNA ligase III. DNA ligase III fractionates through two columns with the maximum in DNA end joining activity and its depletion from the extract causes loss of activity that can be recovered by the addition of purified enzyme. The same fractionation protocols provide evidence for an additional factor strongly enhancing DNA end joining and shifting the product spectrum from circles to multimers. An in vivo plasmid assay shows that DNA ligase IV-deficient mouse embryo fibroblasts retain significant DNA end joining activity that can be reduced by up to 80% by knocking down DNA ligase III using RNA interference. These in vivo and in vitro observations identify DNA ligase III as a candidate component for B-NHEJ and point to additional factors contributing to NHEJ efficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899791     DOI: 10.1158/0008-5472.CAN-04-3055

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  143 in total

1.  Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress.

Authors:  Martina Bauer; Michael Goldstein; Markus Christmann; Huong Becker; Daniel Heylmann; Bernd Kaina
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  DNA ligase III: a spotty presence in eukaryotes, but an essential function where tested.

Authors:  Deniz Simsek; Maria Jasin
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

3.  Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Authors:  Anastazja Grabarz; Aurélia Barascu; Josée Guirouilh-Barbat; Bernard S Lopez
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

4.  Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1).

Authors:  Cristian Boboila; Valentyn Oksenych; Monica Gostissa; Jing H Wang; Shan Zha; Yu Zhang; Hua Chai; Cheng-Sheng Lee; Mila Jankovic; Liz-Marie Albertorio Saez; Michel C Nussenzweig; Peter J McKinnon; Frederick W Alt; Bjoern Schwer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

5.  Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.

Authors:  L A Tobin; C Robert; A P Rapoport; I Gojo; M R Baer; A E Tomkinson; F V Rassool
Journal:  Oncogene       Date:  2012-05-28       Impact factor: 9.867

Review 6.  The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers.

Authors:  Yu Zhang; Monica Gostissa; Dominic G Hildebrand; Michael S Becker; Cristian Boboila; Roberto Chiarle; Susanna Lewis; Frederick W Alt
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 7.  DNA damage and repair during lymphoid development: antigen receptor diversity, genomic integrity and lymphomagenesis.

Authors:  Nahum Puebla-Osorio; Chengming Zhu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  Alternative endings.

Authors:  James E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-07       Impact factor: 11.205

9.  Mechanisms of leukemia translocations.

Authors:  Jac A Nickoloff; Leyma P De Haro; Justin Wray; Robert Hromas
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

Review 10.  BRCA1 Mutation: A Predictive Marker for Radiation Therapy?

Authors:  Charlene Kan; Junran Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.